3,6-Anhydro-l-galactonate cycloisomerase (ACI), which is found in the marine bacterium Vibrio sp. strain EJY3, converts 3,6-anhydro-l-galactonate into 2-keto-3-deoxygalactonate. ACI is a key enzyme in the metabolic pathway of 3,6-anhydro-l-galactose (AHG). Study of AHG metabolism is important for the efficient fermentation of agar and biofuel production, because AHG is a sugar that is non-fermentable by commercial microorganisms. The aci gene from Vibrio sp. strain EJY3 was cloned, and the recombinant protein was overexpressed and crystallized in order to determine the structure and understand the function of the protein. The crystals diffracted to 2.2 Å resolution and belonged to space group P4 1 2 1 2 or P4 3 2 1 2, with unit-cell parameters a = b = 87.9, c = 143.5 Å . The Matthews coefficient was 2.3 Å 3 Da À1 , with a solvent content of 47%. research communications 514 Lee et al. 3,6-Anhydro-L-galactonate cycloisomerase Acta Cryst. (2017). F73, 511-514 Figure 4
Introduction
3,6-Anhydro-l-galactose (AHG) is a monomeric unit of agar polysaccharides and is a rare sugar that is only found in marine red algal biomass (Day & Yaphe, 1975; . Recently, microbial AHG metabolism has been revealed through the study of Vibrio sp. strain EJY3, which is capable of growth using AHG as a sole carbon source (Yun, Lee et al., 2015) . AHG is recruited into the central metabolic pathway through successive reactions catalyzed by two key enzymes: AHG dehydrogenase (EC 1.2.1.92; designated AHGD) and 3,6-anhydro-l-galactonate cycloisomerase (EC 5.5.1.25; designated ACI) (Yun, Lee et al., 2015) . AHGD transforms AHG into 3,6-anhydro-l-galactonate (AHGA), a novel metabolite that was reported for the first time in the agar metabolic pathway. The resultant AHGA is converted to 2-keto-3-deoxygalactonate (KDGal) by ACI ( Fig. 1 ; Yun, Lee et al., 2015) . This two-step conversion of AHG to KDGal is a bypass route to the central metabolic pathway for metabolizing AHG as a carbon source.
The enolase superfamily has been divided into seven major subgroups on the basis of sequence, structure and molecular function: (i) mandelate racemases (MRs), (ii) muconatelactonizing enzymes (MLEs), (iii) enolases, (iv) d-mannonate dehydratases (d-ManDs), (v) d-glucarate dehydratases (d-GlucDs), (vi) -methylaspartate ammonia lyases (MALs) and (vii) galactarate dehydratases (GalcDs) (Babbitt et al., 1996; Lukk et al., 2012) . The overall reaction of the enolase super-
# 2017 International Union of Crystallography family involves the Mg 2+ -assisted enolization of a carboxylate anion substrate (Gerlt et al., 2005) . The total number of members of the enolase superfamily is greater than 8000, but the exact molecular function of many of the members remains unknown or unclear (Gerlt et al., 2012) . Based on the sequence-structure-function relationship, the ACI enzyme belongs to the MR subgroup of enzymes (Yun, Lee et al., 2015) . However, the crystal structure of ACI, which has molecular function towards the novel substrate AHGA, is unclear. The structure is essential to study the mechanism of the ACI enzyme. In this study, we report the cloning, expression, purification, crystallization and X-ray crystallographic analysis of ACI from Vibrio sp. strain EJY3.
Materials and methods

Macromolecule production
The aci gene from Vibrio sp. strain EJY3 (gene ID 11666919), which encodes 362 amino-acid residues, was amplified by PCR from the genomic DNA of Vibrio sp. strain EJY3 using the forward and reverse primers shown in Table 1 . The PCR products were cloned into the pJL plasmid, which is a modified pET-21a vector with a six-histidine tag at the C-terminus (Lee & Kim, 2009 ). The cloned vector with the aci gene was transformed into Escherichia coli BL21 (DE3) cells. The cells were grown in 1 l Luria-Bertani (LB) medium (BD, USA) containing 100 mg ml À1 ampicillin at 310 K until the OD 600 reached 0.8, and protein expression was then induced by 0.5 mM isopropyl -d-1-thiogalactopyranoside (IPTG) at 289 K for 24 h in a shaking incubator (150 rev min À1 ). The cells were harvested by centrifugation at 5000 rev min À1 for 40 min at 277 K. The harvested cells were lysed by sonication in lysis buffer (20 mM Tris-HCl pH 8.0). To obtain soluble protein, the lysate was centrifuged at 18 000 rev min À1 for 40 min at 277 K. The recombinant protein was purified by Ni 2+ -affinity chromatography using a 5 ml HisTrap HP column (GE Healthcare, USA). The column was equilibrated with 20 mM Tris-HCl pH 8.0. The Vibrio sp. strain EJY3 ACI (VejACI) protein was eluted with a linear gradient of elution buffer (20 mM Tris-HCl pH 8.0, 500 mM imidazole). The eluted protein was further purified by anion-exchange chromatography using a 5 ml HiTrap Q FF column (GE Healthcare, USA) equilibrated with 20 mM Tris-HCl pH 8.0 and eluted with a linear gradient of 0-500 mM NaCl in the same buffer.
Buffer exchange of the VejACI protein was performed using a HiPrep 26/10 desalting column (GE Healthcare, USA) pre-equilibrated with 20 mM Tris-HCl pH 8.0, and the protein was concentrated using a 30 kDa molecular-weight cutoff Centricon centrifugal filter (Millipore, USA) to 15 mg ml À1 for crystallization. The concentration of the purified VejACI was determined using the Bradford assay kit (Bio-Rad, USA) and BSA was used for calibration. Table 1 Macromolecule-production information. Figure 1 Scheme showing the initial metabolic pathway of AHG.
Crystallization
Initial crystallization of VejACI was attempted by the sitting-drop vapour-diffusion method using Crystal Screen HT, Index HT, Natrix (Hampton Research), Wizard 1 & 2 and Wizard 3 & 4 (Rigaku Reagents) in 96-well Intelli-Plates (Hampton Research). All drops were made by mixing 0.2 ml protein solution (15 mg ml À1 ) with an equal volume of reservoir solution on 96-well plates and were equilibrated against 70 ml reservoir solution at 295 K. Crystal optimization was carried out by the hanging-drop vapour-diffusion method at various pH values and precipitant concentrations. Bipyramidal crystals of VejACI were obtained in 0.2 M magnesium chloride hexahydrate, 0.1 M bis-tris pH 6.5, 25%(w/v) polyethylene glycol 3350 at 295 K after one week ( Table 2 ). The diffractionquality crystals grew to 0.2 Â 0.15 Â 0.15 mm in size.
X-ray data collection and processing
Crystals were mounted on a nylon loop (Hampton Research, USA). X-ray diffraction data were collected on beamline 7A at Pohang Accelerator Laboratory (PAL). The best diffraction data for VejACI were collected over a 360 oscillation range at a wavelength of 0.97934 Å . All diffraction images were recorded using an ADSC Quantum 270r detector at a crystal-to-detector distance of 250 mm. All data were processed using HKL-2000 (Otwinowski & Minor, 1997) . The Matthews coefficient was calculated using the CCP4 program suite (Winn et al., 2011) . The data-processing statistics are summarized in Table 3 .
Results and discussion
The Vibrio sp. strain EJY3 aci gene was cloned with a sixhistidine affinity tag at the C-terminus. The recombinant plasmid with the aci gene was transformed into E. coli BL21 (DE3) cells for overexpression. Recombinant VejACI protein expressed in E. coli BL21 (DE3) cells was purified by a twostep purification comprising Ni 2+ -affinity chromatography and anion-exchange chromatography. The protein eluted from the HisTrap HP column at 130 mM imidazole and from the HiTrap Q FF anion-exchange column at 250 mM NaCl. For crystallization, the buffer was exchanged to 20 mM Tris-HCl pH 8.0 using a HiPrep 26/10 desalting column (GE Healthcare, USA). The molecular weight and purity of the VejACI protein were verified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE; Fig. 2 ). The activity of VejACI has been reported previously (Yun, Lee et al., 2015) . VejACI was confirmed to be present in a monomeric form by sizeexclusion chromatography (data not shown).
We performed crystallization screening by the sitting-drop vapour-diffusion method using approximately 500 conditions. Needle-shaped crystals of VejACI were obtained from Crystal Screen condition No. 18 [0.2 M magnesium acetate tetrahydrate, 0.1 M sodium cacodylate trihydrate pH 6.5, 20%(w/v) polyethylene glycol 8000]. Bipyramid-shaped crystals were obtained from Index HT condition No. 83 consisting of 0.2 M magnesium chloride hexahydrate, 0.1 M bis-tris pH 6.5, 25%(w/v) polyethylene glycol 3350 (Fig. 3) . Attempts were made to optimize the crystallization conditions for VejACI by varying the concentration of PEG 3350 (15, 20, 25 and 30%) and the pH of the buffer (6.0-7.0) based on the initial crystallization conditions. The best crystal of VejACI was obtained from the initial crystallization conditions. The bipyramid-shaped crystals diffracted to 2.20 Å resolution using synchrotron radiation at PAL (Fig. 4) . The crystals belonged to the tetragonal space group P4 1 2 1 2 or P4 3 2 1 2, with unit-cell parameters a = b = 87.9, c = 143.5 Å . The Matthews coefficient (Matthews, 1968 ) was 2.3 Å 3 Da À1 , with a solvent content of 47%, suggesting that the asymmetric unit contained one VejACI molecule. A total of 397 120 reflections in the resolution range 50.00-2.20 Å were merged into 29 525 unique reflections with an R merge of 0.137. The ACI enzyme has substrate specificity towards the novel metabolite AHGA. The crystal structure of the ACI enzyme involved in the molecular function of AHGA is unknown. Therefore, the crystal structure of ACI is required to investigate the reaction mechanism of ACI on AHGA at the molecular level. Structural analysis of ACI will provide a guide for the design of an efficient biocatalyst for use in the production or bioconversion of AHGA. Structure determination of VejACI by molecular replacement is in progress.
